|
US6387373B1
(en)
*
|
1993-01-15 |
2002-05-14 |
Novavax, Inc. |
Vaccines containing paucilsmellar lipid vesicles as immunological adjuvants
|
|
US6542183B1
(en)
|
1995-06-28 |
2003-04-01 |
Lynx Systems Developers, Inc. |
Event recording apparatus
|
|
US5766629A
(en)
|
1995-08-25 |
1998-06-16 |
Sangstat Medical Corporation |
Oral cyclosporin formulations
|
|
US6958148B1
(en)
|
1998-01-20 |
2005-10-25 |
Pericor Science, Inc. |
Linkage of agents to body tissue using microparticles and transglutaminase
|
|
KR100342835B1
(ko)
*
|
1998-07-31 |
2002-07-02 |
박호군 |
유전자 또는 약물을 효과적으로 전달하는 지방유제, 제형 및 이들의 제조방법
|
|
US6284234B1
(en)
*
|
1998-08-04 |
2001-09-04 |
Johnson & Johnson Consumer Companies, Inc. |
Topical delivery systems for active agents
|
|
US20020054914A1
(en)
*
|
1999-02-03 |
2002-05-09 |
Tulin Morcol |
Compositions and methods for therapuetic agents complexed with calcium phosphate and encased by casein
|
|
US6355271B1
(en)
*
|
1999-02-03 |
2002-03-12 |
Biosante Pharmaceuticals, Inc. |
Therapeutic calcium phosphate particles and methods of manufacture and use
|
|
US20040258763A1
(en)
*
|
1999-02-03 |
2004-12-23 |
Bell Steve J.D. |
Methods of manufacture and use of calcium phosphate particles containing allergens
|
|
US7374779B2
(en)
*
|
1999-02-26 |
2008-05-20 |
Lipocine, Inc. |
Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
|
|
US6248363B1
(en)
*
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
US8236335B2
(en)
|
1999-04-28 |
2012-08-07 |
The Regents Of The University Of Michigan |
Antimicrobial nanoemulsion compositions and methods
|
|
US7767216B2
(en)
|
1999-04-28 |
2010-08-03 |
The Regents Of The University Of Michigan |
Antimicrobial compositions and methods of use
|
|
US7655252B2
(en)
|
1999-04-28 |
2010-02-02 |
The Regents Of The University Of Michigan |
Antimicrobial nanoemulsion compositions and methods
|
|
US20030236236A1
(en)
*
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
|
JP4751556B2
(ja)
|
2000-02-28 |
2011-08-17 |
ジーンシーグス， インコーポレイテッド |
ナノカプセルカプセル化システムおよび方法
|
|
AU8206401A
(en)
|
2000-08-03 |
2002-02-18 |
Antares Pharma Ipl Ag |
Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
|
|
US8980290B2
(en)
|
2000-08-03 |
2015-03-17 |
Antares Pharma Ipl Ag |
Transdermal compositions for anticholinergic agents
|
|
US20070225379A1
(en)
*
|
2001-08-03 |
2007-09-27 |
Carrara Dario Norberto R |
Transdermal delivery of systemically active central nervous system drugs
|
|
US20040198706A1
(en)
*
|
2003-03-11 |
2004-10-07 |
Carrara Dario Norberto R. |
Methods and formulations for transdermal or transmucosal application of active agents
|
|
US7198801B2
(en)
*
|
2000-08-03 |
2007-04-03 |
Antares Pharma Ipl Ag |
Formulations for transdermal or transmucosal application
|
|
US6423707B1
(en)
|
2000-08-28 |
2002-07-23 |
California Pacific Medical Center |
Nitroimidazole ester analogues and therapeutic applications
|
|
US20040002482A1
(en)
*
|
2000-08-30 |
2004-01-01 |
Dudley Robert E. |
Androgen pharmaceutical composition and method for treating depression
|
|
US20040092494A9
(en)
*
|
2000-08-30 |
2004-05-13 |
Dudley Robert E. |
Method of increasing testosterone and related steroid concentrations in women
|
|
US6503894B1
(en)
|
2000-08-30 |
2003-01-07 |
Unimed Pharmaceuticals, Inc. |
Pharmaceutical composition and method for treating hypogonadism
|
|
US6537591B2
(en)
|
2001-03-02 |
2003-03-25 |
Aquarium Pharmaceuticals, Inc. |
Aquatic animal treatment method and composition containing Pimenta extract
|
|
US20030185892A1
(en)
*
|
2001-08-17 |
2003-10-02 |
Bell Steve J. D. |
Intraocular delivery compositions and methods
|
|
NZ531492A
(en)
*
|
2001-08-28 |
2007-11-30 |
Eden Research Plc |
Treatment and prevention of fungal, bacterial, mycoplasma and phytoplasma infections in plants comprising terpene compounds in true solution
|
|
US20050233003A1
(en)
*
|
2001-09-28 |
2005-10-20 |
Solubest Ltd. |
Hydrophilic dispersions of nanoparticles of inclusion complexes of salicylic acid
|
|
US6878693B2
(en)
*
|
2001-09-28 |
2005-04-12 |
Solubest Ltd. |
Hydrophilic complexes of lipophilic materials and an apparatus and method for their production
|
|
US20050227911A1
(en)
*
|
2001-09-28 |
2005-10-13 |
Solubest Ltd. |
Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules
|
|
US11207805B2
(en)
|
2001-10-12 |
2021-12-28 |
Aquestive Therapeutics, Inc. |
Process for manufacturing a resulting pharmaceutical film
|
|
US10285910B2
(en)
|
2001-10-12 |
2019-05-14 |
Aquestive Therapeutics, Inc. |
Sublingual and buccal film compositions
|
|
US8663687B2
(en)
*
|
2001-10-12 |
2014-03-04 |
Monosol Rx, Llc |
Film compositions for delivery of actives
|
|
US20110033542A1
(en)
|
2009-08-07 |
2011-02-10 |
Monosol Rx, Llc |
Sublingual and buccal film compositions
|
|
US8765167B2
(en)
|
2001-10-12 |
2014-07-01 |
Monosol Rx, Llc |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
|
US8603514B2
(en)
|
2002-04-11 |
2013-12-10 |
Monosol Rx, Llc |
Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
|
|
US20190328679A1
(en)
|
2001-10-12 |
2019-10-31 |
Aquestive Therapeutics, Inc. |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
|
US7357891B2
(en)
|
2001-10-12 |
2008-04-15 |
Monosol Rx, Llc |
Process for making an ingestible film
|
|
US8900497B2
(en)
|
2001-10-12 |
2014-12-02 |
Monosol Rx, Llc |
Process for making a film having a substantially uniform distribution of components
|
|
US20070281003A1
(en)
|
2001-10-12 |
2007-12-06 |
Fuisz Richard C |
Polymer-Based Films and Drug Delivery Systems Made Therefrom
|
|
US8900498B2
(en)
|
2001-10-12 |
2014-12-02 |
Monosol Rx, Llc |
Process for manufacturing a resulting multi-layer pharmaceutical film
|
|
US7700851B2
(en)
*
|
2001-11-13 |
2010-04-20 |
U.S. Smokeless Tobacco Company |
Tobacco nicotine demethylase genomic clone and uses thereof
|
|
US20030180349A1
(en)
*
|
2001-12-07 |
2003-09-25 |
Franklin Lanny U. |
Respiratory infection prevention and treatment with terpene-containing compositions
|
|
US7763663B2
(en)
*
|
2001-12-19 |
2010-07-27 |
University Of Massachusetts |
Polysaccharide-containing block copolymer particles and uses thereof
|
|
US20030228402A1
(en)
*
|
2002-02-19 |
2003-12-11 |
Franklin Lanny U. |
Compositions and methods for preservation of food
|
|
EP1487504A4
(en)
*
|
2002-02-19 |
2010-09-01 |
Eden Research Plc |
IMPROVING THE QUALITY OF THE INTERIOR AIR AND ANTISEPTIC COMPOSITION INTENDED FOR THIS PURPOSE
|
|
US20040038303A1
(en)
*
|
2002-04-08 |
2004-02-26 |
Unger Gretchen M. |
Biologic modulations with nanoparticles
|
|
US20040087564A1
(en)
*
|
2002-10-31 |
2004-05-06 |
Wright D. Craig |
Delivery composition and method
|
|
US20050208083A1
(en)
|
2003-06-04 |
2005-09-22 |
Nanobio Corporation |
Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
|
|
EP1670433B1
(en)
|
2003-10-10 |
2011-11-23 |
Antares Pharma IPL AG |
Transdermal pharmaceutical formulation for minimizing skin residues
|
|
US20050084513A1
(en)
*
|
2003-10-21 |
2005-04-21 |
Board Of Regents |
Nanocoating for improving biocompatibility of medical implants
|
|
US20050084456A1
(en)
*
|
2003-10-21 |
2005-04-21 |
Liping Tang |
Functionalized particles
|
|
EP1711058B1
(en)
|
2004-01-23 |
2021-09-15 |
Eden Research Plc |
Methods of killing nematodes comprising the application of a terpene component
|
|
CN1993113B
(zh)
*
|
2004-02-13 |
2010-12-08 |
Nod药物公司 |
包含磷酸钙纳米颗粒核心，生物分子和胆汁酸的颗粒，其生产方法，其治疗用途
|
|
US7425340B2
(en)
*
|
2004-05-07 |
2008-09-16 |
Antares Pharma Ipl Ag |
Permeation enhancing compositions for anticholinergic agents
|
|
PT1753529E
(pt)
|
2004-05-20 |
2013-11-18 |
Eden Research Plc |
Composições contendo uma partícula oca de glucano ou uma partícula de parede celular encapsulando um componente de terpeno, e métodos para a sua produção e utilização
|
|
WO2006036967A1
(en)
|
2004-09-28 |
2006-04-06 |
Atrium Medical Corporation |
Solubilizing a drug for use in a coating
|
|
EP1812022B1
(en)
|
2004-09-28 |
2014-01-15 |
Atrium Medical Corporation |
Stand-alone film and methods for making the same
|
|
US9000040B2
(en)
|
2004-09-28 |
2015-04-07 |
Atrium Medical Corporation |
Cross-linked fatty acid-based biomaterials
|
|
US9801982B2
(en)
|
2004-09-28 |
2017-10-31 |
Atrium Medical Corporation |
Implantable barrier device
|
|
US9012506B2
(en)
|
2004-09-28 |
2015-04-21 |
Atrium Medical Corporation |
Cross-linked fatty acid-based biomaterials
|
|
WO2006050368A2
(en)
|
2004-11-01 |
2006-05-11 |
Biosante Pharmaceuticals, Inc. |
Therapeutic calcium phosphate particles iin use for aesthetic or cosmetic medicine, and methods of manufacture and use
|
|
US20070088012A1
(en)
*
|
2005-04-08 |
2007-04-19 |
Woun Seo |
Method of treating or preventing type-2 diabetes
|
|
US7371738B2
(en)
*
|
2005-04-15 |
2008-05-13 |
University Of South Florida |
Method of transdermal drug delivery using hyaluronic acid nanoparticles
|
|
WO2006125642A1
(en)
|
2005-05-27 |
2006-11-30 |
Antares Pharma Ipl Ag |
Methods and apparatus for transdermal or transmucosal application of testosterone
|
|
JP5368793B2
(ja)
|
2005-07-18 |
2013-12-18 |
ユニバーシティ オブ マサチューセッツ ロウエル |
ナノエマルジョンを製造および使用するための組成物および方法
|
|
US9427423B2
(en)
|
2009-03-10 |
2016-08-30 |
Atrium Medical Corporation |
Fatty-acid based particles
|
|
US9278161B2
(en)
|
2005-09-28 |
2016-03-08 |
Atrium Medical Corporation |
Tissue-separating fatty acid adhesion barrier
|
|
SI1937276T1
(sl)
|
2005-10-12 |
2013-04-30 |
Unimed Pharmaceuticals, Llc C/O Abbott Laboratoires 100 Abbott Park Road |
Izboljšani testosteronski gel in postopek uporabe
|
|
AU2006304640B2
(en)
|
2005-10-18 |
2012-10-11 |
Novavax, Inc. |
Functional influenza virus like particles (VLPs)
|
|
KR20140103191A
(ko)
|
2005-11-30 |
2014-08-25 |
에덴 리서치 피엘씨 |
티몰, 유게놀, 게라니올, 시트랄, 및 ｌ―카르본에서 선택된 테르펜 또는 테르펜 혼합물을 포함하는 조성물 및 방법
|
|
US10667512B2
(en)
|
2005-11-30 |
2020-06-02 |
Eden Research Plc |
Terpene-containing compositions and methods of making and using them
|
|
PT3144013T
(pt)
|
2005-12-01 |
2019-02-07 |
Univ Massachusetts Lowell |
Nanoemulsões botulínicas
|
|
US9486408B2
(en)
|
2005-12-01 |
2016-11-08 |
University Of Massachusetts Lowell |
Botulinum nanoemulsions
|
|
EP2001439A2
(en)
*
|
2006-03-07 |
2008-12-17 |
Novavax, Inc. |
Nanoemulsions of poorly soluble pharmaceutical active ingredients and methods of making the same
|
|
US10137083B2
(en)
*
|
2006-03-07 |
2018-11-27 |
SGN Nanopharma Inc |
Ophthalmic preparations
|
|
US11311477B2
(en)
|
2006-03-07 |
2022-04-26 |
Sgn Nanopharma Inc. |
Ophthalmic preparations
|
|
CN101466355A
(zh)
*
|
2006-04-07 |
2009-06-24 |
诺瓦瓦克斯股份有限公司 |
具有抗细菌、抗真菌、抗酵母和/或抗病毒性质的纳米化组合物
|
|
CN101426475A
(zh)
|
2006-04-21 |
2009-05-06 |
安塔雷斯制药Ipl股份公司 |
使用用于经皮或经粘膜应用的制剂治疗热潮红的方法
|
|
US8715949B2
(en)
*
|
2006-09-07 |
2014-05-06 |
The United States Of America, As Represented By The Secretary Of The Navy |
Applications of the binding interaction of proanthocyanidins with bacteria and bacterial components
|
|
US20080139513A1
(en)
*
|
2006-09-26 |
2008-06-12 |
Novavax, Inc. |
Transdermal deliver of active agents
|
|
US9492596B2
(en)
|
2006-11-06 |
2016-11-15 |
Atrium Medical Corporation |
Barrier layer with underlying medical device and one or more reinforcing support structures
|
|
EP2083875B1
(en)
|
2006-11-06 |
2013-03-27 |
Atrium Medical Corporation |
Coated surgical mesh
|
|
BRPI0719756A2
(pt)
*
|
2006-12-01 |
2014-01-21 |
Anterios Inc |
Nanopartículas de entidades anfifílicas
|
|
AU2007353340A1
(en)
*
|
2006-12-01 |
2008-11-20 |
Anterios, Inc. |
Peptide nanoparticles and uses therefor
|
|
WO2008067991A2
(en)
*
|
2006-12-08 |
2008-06-12 |
Antares Pharma Ipl Ag |
Skin-friendly drug complexes for transdermal administration
|
|
US20080207756A1
(en)
*
|
2007-02-27 |
2008-08-28 |
Atrium Medical Corporation |
Bio-absorbable oil suspension
|
|
EP2152304B1
(en)
|
2007-05-02 |
2018-08-22 |
The Regents of the University of Michigan |
Nanoemulsion therapeutic compositions and methods of using the same
|
|
WO2008151022A2
(en)
|
2007-05-31 |
2008-12-11 |
Anterios, Inc. |
Nucleic acid nanoparticles and uses therefor
|
|
CA2693899A1
(en)
|
2007-07-19 |
2009-01-22 |
Novavax, Inc. |
Chimeric varicella zoster virus-virus like particles
|
|
KR102080429B1
(ko)
*
|
2008-06-26 |
2020-02-21 |
안테리오스, 인코퍼레이티드 |
경피 운반
|
|
WO2010057197A1
(en)
|
2008-11-17 |
2010-05-20 |
The Regents Of The University Of Michigan |
Cancer vaccine compositions and methods of using the same
|
|
HRP20160859T1
(hr)
|
2008-12-09 |
2016-09-23 |
Novavax, Inc. |
Modificirani proteini rsv f i postupci njihove upotrebe
|
|
US11304960B2
(en)
*
|
2009-01-08 |
2022-04-19 |
Chandrashekar Giliyar |
Steroidal compositions
|
|
JP2012523408A
(ja)
|
2009-04-08 |
2012-10-04 |
カディラ・ヘルスケア・リミテッド |
ジクロフェナクの安定な医薬組成物
|
|
US8470304B2
(en)
|
2009-08-04 |
2013-06-25 |
Avidas Pharmaceuticals Llc |
Therapeutic vitamin D sun-protecting formulations and methods for their use
|
|
US20110038910A1
(en)
|
2009-08-11 |
2011-02-17 |
Atrium Medical Corporation |
Anti-infective antimicrobial-containing biomaterials
|
|
US20110045050A1
(en)
*
|
2009-08-24 |
2011-02-24 |
Atrium Medical Corporation |
Nanoemulsion formulations for direct delivery
|
|
WO2012009707A2
(en)
|
2010-07-16 |
2012-01-19 |
Atrium Medical Corporation |
Composition and methods for altering the rate of hydrolysis of cured oil-based materials
|
|
WO2012053009A2
(en)
|
2010-10-21 |
2012-04-26 |
Cadila Healthcare Limited |
Pharmaceutical compositions comprising skin whitening agents
|
|
WO2012053008A1
(en)
|
2010-10-21 |
2012-04-26 |
Cadila Healthcare Limited |
Topical pharmaceutical compositions comprising etodolac
|
|
WO2012053013A2
(en)
|
2010-10-21 |
2012-04-26 |
Cadila Healthcare Limited |
Pharmaceutical compositions of anti-acne agents
|
|
MX2013004296A
(es)
|
2010-10-21 |
2013-09-26 |
Cadila Healthcare Ltd |
Composiciones farmaceuticas topicas que contienen gotas de tamaño nanometrico para el tratamiento de soriasis.
|
|
US9789123B2
(en)
|
2010-10-21 |
2017-10-17 |
Cadila Healthcare Limited |
Topical pharmaceutical compositions containing nanodroplets for the treatment of psoriasis
|
|
WO2012053012A2
(en)
|
2010-10-21 |
2012-04-26 |
Cadila Healthcare Limited |
Topical pharmaceutical compositions comprising tfflocolchicoside
|
|
US9149959B2
(en)
|
2010-10-22 |
2015-10-06 |
Monosol Rx, Llc |
Manufacturing of small film strips
|
|
WO2012059936A1
(en)
|
2010-11-03 |
2012-05-10 |
Padma Venkitachalam Devarajan |
Pharmaceutical compositions for colloidal drug delivery
|
|
KR101847908B1
(ko)
|
2010-11-05 |
2018-04-11 |
노바백스, 인코포레이티드 |
광견병 당단백질 바이러스-유사 입자(VLPs)
|
|
US9358241B2
(en)
|
2010-11-30 |
2016-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
|
US20180153904A1
(en)
|
2010-11-30 |
2018-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
|
US9034858B2
(en)
|
2010-11-30 |
2015-05-19 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
|
US20120148675A1
(en)
|
2010-12-10 |
2012-06-14 |
Basawaraj Chickmath |
Testosterone undecanoate compositions
|
|
CA2818691C
(en)
|
2010-12-21 |
2021-08-03 |
Science Applications International Corporation |
Methods to identify actin or rdg peptide motifs in wound sites and compositions and methods for wound treatment
|
|
US20120189677A1
(en)
*
|
2011-01-20 |
2012-07-26 |
Stephen Tonge |
Formulations
|
|
WO2012127496A1
(en)
|
2011-03-01 |
2012-09-27 |
Cadila Healthcare Limited |
Stable pharmaceutical compositions of lornoxicam or salts thereof
|
|
WO2013003803A1
(en)
|
2011-06-29 |
2013-01-03 |
Avidas Pharmaceuticals Llc |
Topical formulations including lipid microcapsule delivery vehicles and their uses
|
|
WO2013014680A1
(en)
|
2011-07-28 |
2013-01-31 |
Cadila Healthcare Limited |
Method for treatment of pain and inflammation
|
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
|
CA2856520C
(en)
|
2011-11-23 |
2021-04-06 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
|
US10322089B2
(en)
*
|
2012-03-14 |
2019-06-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
Nanoparticles, nanoparticle delivery methods, and systems of delivery
|
|
US9867880B2
(en)
|
2012-06-13 |
2018-01-16 |
Atrium Medical Corporation |
Cured oil-hydrogel biomaterial compositions for controlled drug delivery
|
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
|
GB201220940D0
(en)
|
2012-11-21 |
2013-01-02 |
Eden Research Plc |
Method P
|
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
RU2685185C2
(ru)
|
2013-09-19 |
2019-04-16 |
Новавакс, Инк. |
Иммуногенные композиции коронавируса ближневосточного респираторного синдрома (mers-cov) и способы
|
|
AR100562A1
(es)
|
2014-05-22 |
2016-10-12 |
Therapeuticsmd Inc |
Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
|
|
US20170246187A1
(en)
|
2014-08-28 |
2017-08-31 |
Lipocine Inc. |
(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
|
|
WO2016033556A1
(en)
|
2014-08-28 |
2016-03-03 |
Lipocine Inc. |
BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
|
|
CA2959660A1
(en)
|
2014-09-03 |
2016-03-10 |
Genesegues, Inc. |
Therapeutic nanoparticles and related compositions, methods, and systems
|
|
US10894024B2
(en)
*
|
2014-12-08 |
2021-01-19 |
Synaptamine, Inc. |
Anti-RDS compounds and method of manufacture and administration thereof to induce dopamine homeostatis
|
|
US20160361322A1
(en)
|
2015-06-15 |
2016-12-15 |
Lipocine Inc. |
Composition and method for oral delivery of androgen prodrugs
|
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
|
WO2017041100A2
(en)
|
2015-09-03 |
2017-03-09 |
Novavax, Inc. |
Vaccine compositions having improved stability and immunogenicity
|
|
AU2017239645A1
(en)
|
2016-04-01 |
2018-10-18 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical composition
|
|
US10286077B2
(en)
|
2016-04-01 |
2019-05-14 |
Therapeuticsmd, Inc. |
Steroid hormone compositions in medium chain oils
|
|
US12433850B2
(en)
|
2016-05-05 |
2025-10-07 |
Aquestive Therapeutics, Inc. |
Enhanced delivery epinephrine and prodrug compositions
|
|
US12427121B2
(en)
|
2016-05-05 |
2025-09-30 |
Aquestive Therapeutics, Inc. |
Enhanced delivery epinephrine compositions
|
|
US11273131B2
(en)
|
2016-05-05 |
2022-03-15 |
Aquestive Therapeutics, Inc. |
Pharmaceutical compositions with enhanced permeation
|
|
CA3022840A1
(en)
|
2016-05-05 |
2017-11-09 |
Aquestive Therapeutics, Inc. |
Enhanced delivery epinephrine compositions
|
|
KR102487144B1
(ko)
|
2016-11-21 |
2023-01-12 |
에이리온 테라퓨틱스, 인코포레이티드 |
큰 물질의 경피 전달
|
|
US11559530B2
(en)
|
2016-11-28 |
2023-01-24 |
Lipocine Inc. |
Oral testosterone undecanoate therapy
|
|
US12083228B2
(en)
|
2017-07-24 |
2024-09-10 |
Novavax, Inc. |
Methods and compositions for treating respiratory disease
|
|
CA3107214A1
(en)
|
2018-07-20 |
2020-01-23 |
Lipocine Inc. |
Liver disease
|
|
CN110881462A
(zh)
*
|
2019-11-25 |
2020-03-17 |
南京启佑生物科技有限公司 |
一种基于磷酸盐与金属离子的纳米农药复合制剂及其制备方法
|
|
US10953089B1
(en)
|
2020-01-27 |
2021-03-23 |
Novavax, Inc. |
Coronavirus vaccine formulations
|
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|
|
EP4422607A4
(en)
|
2021-10-25 |
2025-09-03 |
Aquestive Therapeutics Inc |
ORAL AND NASAL COMPOSITIONS AND METHODS OF TREATMENT
|
|
US20250085282A1
(en)
|
2023-09-11 |
2025-03-13 |
Novavax, Inc. |
Method for detecting anti-sars-cov-2 spike (s) immunoglobulins
|
|
US20250144200A1
(en)
|
2023-11-06 |
2025-05-08 |
Novavax, Inc. |
Intranasal immunogenic compositions
|